Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Restylane Vital Light is a specialized dermal filler and skin rejuvenation product composed of non-animal stabilized hyaluronic acid (NASHA). It is part of the Restylane Skinboosters line developed by Q-Med (a Galderma company). Unlike high-viscosity fillers used for deep tissue augmentation or contouring, Restylane Vital Light is designed for skin boosting, which involves improving skin hydration, elasticity, and overall quality. It is particularly suited for delicate or thin-skinned areas such as the neck, décolletage, and the dorsal aspect of the hands. The treatment involves multiple micro-injections into the dermis to restore the skin's hydro-balance and stimulate collagen production over time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Restylane Vital Light.